The New Frontier in DCIS Risk Assessment
Manage episode 486656009 series 3595408
In this episode, host Dr. Reni Butler speaks with Dr. Kalina Slavkova, Dr. Ruya Kang, Dr. Despina Kontos, and Dr. Habib Rahbar about their groundbreaking research using MRI-based radiomic features to improve risk stratification in ductal carcinoma in situ (DCIS). The discussion explores how combining clinical data, imaging, and AI-driven analysis could help personalize treatment and reduce overtreatment in breast cancer care.
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Slavkova and Kang et al. Radiology 2025; 315(1):e241628.254 episodes